Baird analyst Eric Coldwell raised the firm’s price target on AmerisourceBergen to $201 from $199 and keeps an Outperform rating on the shares. The analyst noted they beat on earnings in a choppy market with solid U.S. and International utilization, upbeat on specialty and biosimilars, and flexing their capital deployment muscle.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ABC:
- AmerisourceBergen raises FY23 adjusted EPS view to $11.50-$11.75
- AmerisourceBergen reports Q1 adjusted EPS $2.71, consensus $2.63
- Notable companies reporting before tomorrow’s open
- AmerisourceBergen price target raised to $190 from $184 at UBS
- AmerisourceBergen resumed with an Outperform at Evercore ISI
